Shares Magazine
47.50p+2.50 (+5.56%)18 Dec 2024, 16:29
Jump to:
Avacta Group PLC Fundamentals
| Company Name | Avacta Group PLC | Last Updated | 2024-12-18 |
|---|---|---|---|
| Industry | Biotechnology | Sector | Healthcare |
| Shares in Issue | 366.524 m | Market Cap | £174.10 m |
| PE Ratio | 0.00 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | -£0.09 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0.2490 | Debt Equity Ratio | 0.1135 |
| Asset Equity Ratio | 1.8540 | Cash Equity Ratio | 0.6755 |
| Quick Ratio | 1.1376 | Current Ratio | 1.29 |
| Price To Book Value | 3.6153 | ROCE | 0 |
Avacta Group PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Avacta Group PLC Company Financials
| Assets | 2023 | 2022 | 2021 |
|---|---|---|---|
| Tangible Assets | £9.98 m | £7.80 m | £4.34 m |
| Intangible Assets | £30.84 m | £26.32 m | £7.92 m |
| Investments | £4.08 m | £2.98 m | 0 |
| Total Fixed Assets | £45.16 m | £37.37 m | £12.27 m |
| Stocks | £2.58 m | £1.68 m | £189,000.00 |
| Debtors | £4.49 m | £3.72 m | £1.74 m |
| Cash & Equivalents | £16.63 m | £41.78 m | £26.19 m |
| Other Assets | £261,000.00 | £274,000.00 | 0 |
| Total Assets | £73.19 m | £92.92 m | £47.00 m |
| Liabilities | 2023 | 2022 | 2021 |
|---|---|---|---|
| Creditors within 1 year | £45.11 m | £67.61 m | £4.37 m |
| Creditors after 1 year | £6.28 m | £4.32 m | £1.41 m |
| Other Liabilities | 0 | 0 | £346,000.00 |
| Total Liabilities | £51.39 m | £71.93 m | £5.78 m |
| Net assets | £21.80 m | £21.00 m | £41.22 m |
| Equity | 2023 | 2022 | 2021 |
|---|---|---|---|
| Called up share capital | £28.42 m | £26.61 m | £25.39 m |
| Share Premium | £83.22 m | £62.18 m | £54.53 m |
| Profit / Loss | -£27.32 m | -£41.64 m | -£29.19 m |
| Other Equity | £21.80 m | £21.00 m | £41.22 m |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | £21.80 m | £21.00 m | £41.22 m |
| Ratios | 2023 | 2022 | 2021 |
|---|---|---|---|
| Debt Ratio | £0.21 | £0.15 | £0.03 |
| Debt-to-Equity | £0.27 | £0.18 | £0.03 |
| Assets / Equity | 1.8540 | 1.8540 | 1.8540 |
| Cash / Equity | 0.6755 | 0.6755 | 0.6755 |
| EPS | -£0.13 | -£0.11 | -£0.11 |
| Cash Flow | 2023 | 2022 | 2021 |
|---|---|---|---|
| Cash from operating activities | -£14.87 m | -£16.43 m | -£20.51 m |
| Cashflow before financing | -£16.17 m | £40.47 m | -£20.27 m |
| Increase in Cash | -£25.17 m | £15.43 m | -£1.57 m |
| Income | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | £23.25 m | £9.65 m | £2.94 m |
| Cost of sales | £12.00 m | £2.41 m | £924,000.00 |
| Gross Profit | £11.24 m | £7.24 m | £2.02 m |
| Operating Profit | -£28.36 m | -£32.65 m | -£29.08 m |
| Pre-Tax profit | -£27.32 m | -£41.64 m | -£29.19 m |
Avacta Group PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and precision tumor-targeted chemotherapy. The company operates in the United Kingdom, France, South Korea, Rest of Europe, Asia, and North America. |
| Latest Interim Date | 30 Sep 2024 |
| Latest Fiscal Year End Date | 30 Apr 2024 |
Avacta Group PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2024-05-31 | Dr. Trevor John Nicholls | Non-Executive Director |
| 2011-12-15 | Dr. Barry Porter | Non-Executive Director |
| 2015-01-23 | Dr. Gwynfor Owen Humphreys | Non-Executive Director |
| 2024-06-03 | Professor Dr. David Alastair MacLaughlin Smith | Executive Director,Chief Executive Officer |
| 2019-01-21 | Mr. Alan John Aubrey | Non-Executive Director |
| 2024-06-26 | Mr. Tony Peter Gardiner | Executive Director,Chief Financial Officer and Company Secretary |
| 2016-12-02 | Mr. Timothy James Sykes | Executive Director,Chief Financial Officer and Co Secretary |
| 2014-01-24 | Professor Anthony William Robards, OBE | Non-Executive Director |
| 2017-12-05 | Mr. Craig Slater | Executive Director,Chief Operating Officer |
| 2005-04-30 | Mr. Kui Man Yeung | Non-Executive Director |
| 2011-08-09 | Dr. Simon Webster, PhD | Executive Director,Chief Scientific Officer |
| 2011-08-09 | Dr. Kurt Justin Baldwin, M.Sc.,PhD | Executive Director,Chief Technology Officer |
| 2011-08-09 | Mr. Russell Winston Hodgetts | Executive Director,Chief Operating Officer |
| 2024-05-31 | Mr. Shaun Edward Chilton | Non-Executive Director,Chairman |
| 2018-03-29 | Dr. Michael Scott Albin | Non-Executive Director |
| 2019-11-04 | Dr. Samuel Cameron Williams | Non-Executive Director |
| 2021-03-25 | Dr. Michael John Owen | Non-Executive Director,Senior Independent Director |
| 2024-06-20 | Dr. Eliot Richard Forster, M.B.A.,PhD | Non-Executive Director,Chairman |
| 2024-05-31 | Mr. Paul Andrew Fry | Non-Executive Director |
| 2024-09-02 | Dr. Christina Marie Coughlin | Executive Director,Chief Executive Officer |
Avacta Group PLC Contact Details
| Company Name | Avacta Group PLC |
|---|---|
| Address | Unit 20, Ash Way, Thorp Arch Estate, Wetherby, LS23 7FA |
| Telephone | +44 1904217070 |
| Website | https://www.avacta.com |
Avacta Group PLC Advisors
| Stockbroker | WG Partners |
|---|
| Stockbroker | FinnCap |
|---|---|
| Phone | +44 2072200500 |
| Fax | +44 2076001659 |
| Nominated Adviser | FinnCap |
|---|---|
| Phone | +44 2072200500 |
| Fax | +44 2076001659 |
| Financial PR Adviser | FTI Consulting Inc |
|---|---|
| Phone | +44 2037271000 |
| Fax | +44 2037271007 |
| Auditor | KPMG |
|---|---|
| Phone | +44 1132313000 |
| Fax | +44 1132313200 |
| Solicitor | Walker Morris |
|---|---|
| Phone | +44 1132832500 |
| Fax | +44 1132459412 |
| Bank | National Westminster Bank PLC |
|---|
| Registrar | Capita Asset Services |
|---|---|
| Phone | +44 8716640300 |
| Fax | +44 2086392342 |
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Metro Bank Holdings PLC | 94.30 | 6.80 |
| Ceres Power Holdings PLC | 175.50 | 3.66 |
| Jupiter Fund Management PLC | 86.00 | 3.61 |
| Goodwin PLC | 7,440.00 | 3.05 |
| Bank Of Georgia Group PLC | 4,750.00 | 2.93 |
| Melrose Industries PLC | 553.60 | 2.90 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Integrafin Holdings PLC | 340.50 | -12.69 |
| Osb Group PLC | 392.00 | -6.53 |
| W.A.G Payment Solutions PLC | 78.00 | -4.18 |
| Victrex PLC | 1,092.00 | -2.67 |
| Entain PLC | 732.00 | -2.66 |
| Alpha Group International PLC | 2,250.00 | -2.60 |
Risers/fallers data from previous trading day. Today's data available from 8:15am.